These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23228962)

  • 1. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features.
    Sun Y; Su B; Zhang P; Xie H; Zheng H; Xu Y; Du Q; Zeng H; Zhou X; Chen C; Gao W
    Oncol Rep; 2013 Feb; 29(2):704-12. PubMed ID: 23228962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
    Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
    Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
    He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
    BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
    Wang P; Deng Y; Fu X
    Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.
    Ma Z; Qiu X; Wang D; Li Y; Zhang B; Yuan T; Wei J; Zhao B; Zhao X; Lou J; Jin Y; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):630-8. PubMed ID: 26124189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
    Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
    J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.
    Huang RS; Zheng YL; Li C; Ding C; Xu C; Zhao J
    Life Sci; 2018 Apr; 199():104-111. PubMed ID: 29510198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
    Fan X; Wu X
    J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.
    Li G; Wu F; Yang H; Deng X; Yuan Y
    Biomed Pharmacother; 2017 Dec; 96():1170-1178. PubMed ID: 29239816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.
    Zhuang ZL; Tian FM; Sun CL
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5132-5136. PubMed ID: 28051257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
    Li HS; Lv RQ; Liu L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.